The plasma protein level of MIC-B showed a significant increase in the BC patients [0.941 (range: 0.204–6.38) ng/ml], in comparison to the normal control females [0.351 (range: 0.211–0.884) ng/ml, p < 0.001, Fig. 2C]. Here, MICB is linked to breast cancer.